-
Signature
-
Debra A. Cafaro By: /s/ Kenneth Hagan, Attorney-In-Fact
-
Issuer symbol
-
VTR
-
Transactions as of
-
30 Oct 2025
-
Net transactions value
-
-$3,461,475
-
Form type
-
4
-
Filing time
-
03 Nov 2025, 18:56:47 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| CAFARO DEBRA A |
Chairman and CEO, Director |
C/O VENTAS, INC., 300 NORTH LASALLE ST., SUITE 1600, CHICAGO |
Debra A. Cafaro By: /s/ Kenneth Hagan, Attorney-In-Fact |
03 Nov 2025 |
0001215188 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
VTR |
Common Stock |
Options Exercise |
$1,351,150 |
+20,644 |
+1.8% |
$65.45 |
1,166,339 |
30 Oct 2025 |
Direct |
F1 |
| transaction |
VTR |
Common Stock |
Sale |
$1,534,720 |
-20,644 |
-1.8% |
$74.34 |
1,145,695 |
30 Oct 2025 |
Direct |
F1, F2 |
| transaction |
VTR |
Common Stock |
Options Exercise |
$2,282,504 |
+30,966 |
+2.7% |
$73.71 |
1,176,661 |
30 Oct 2025 |
Direct |
F3 |
| transaction |
VTR |
Common Stock |
Sale |
$2,301,319 |
-30,966 |
-2.6% |
$74.32 |
1,145,695 |
30 Oct 2025 |
Direct |
F3, F4 |
| transaction |
VTR |
Common Stock |
Options Exercise |
$2,611,053 |
+41,288 |
+3.6% |
$63.24 |
1,186,983 |
30 Oct 2025 |
Direct |
F5 |
| transaction |
VTR |
Common Stock |
Sale |
$3,040,345 |
-41,288 |
-3.5% |
$73.64 |
1,145,695 |
30 Oct 2025 |
Direct |
F5, F6 |
| transaction |
VTR |
Common Stock |
Options Exercise |
$13,959,679 |
+224,360 |
+20% |
$62.22 |
1,370,055 |
30 Oct 2025 |
Direct |
F7 |
| transaction |
VTR |
Common Stock |
Sale |
$16,678,384 |
-224,360 |
-16% |
$74.34 |
1,145,695 |
30 Oct 2025 |
Direct |
F7, F8 |
| transaction |
VTR |
Common Stock |
Options Exercise |
$760,835 |
+10,322 |
+0.9% |
$73.71 |
1,156,017 |
03 Nov 2025 |
Direct |
F3 |
| transaction |
VTR |
Common Stock |
Sale |
$763,595 |
-10,322 |
-0.89% |
$73.98 |
1,145,695 |
03 Nov 2025 |
Direct |
F3, F9 |
| transaction |
VTR |
Common Stock |
Options Exercise |
$652,763 |
+10,322 |
+0.9% |
$63.24 |
1,156,017 |
03 Nov 2025 |
Direct |
F5 |
| transaction |
VTR |
Common Stock |
Sale |
$761,096 |
-10,322 |
-0.89% |
$73.74 |
1,145,695 |
03 Nov 2025 |
Direct |
F5, F10 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
VTR |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-20,644 |
-4.6% |
$0.000000 |
430,806 |
30 Oct 2025 |
Common Stock |
20,644 |
$65.45 |
Direct |
F1, F11, F12 |
| transaction |
VTR |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-30,966 |
-7.2% |
$0.000000 |
399,840 |
30 Oct 2025 |
Common Stock |
30,966 |
$73.71 |
Direct |
F3, F11, F12 |
| transaction |
VTR |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-41,288 |
-10% |
$0.000000 |
358,552 |
30 Oct 2025 |
Common Stock |
41,288 |
$63.24 |
Direct |
F5, F11, F12 |
| transaction |
VTR |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-224,360 |
-63% |
$0.000000 |
134,192 |
30 Oct 2025 |
Common Stock |
224,360 |
$62.22 |
Direct |
F7, F11, F12 |
| transaction |
VTR |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-10,322 |
-7.7% |
$0.000000 |
123,870 |
03 Nov 2025 |
Common Stock |
10,322 |
$73.71 |
Direct |
F3, F11, F12 |
| transaction |
VTR |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-10,322 |
-8.3% |
$0.000000 |
113,548 |
03 Nov 2025 |
Common Stock |
10,322 |
$63.24 |
Direct |
F5, F11, F12 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: